BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 20924035)

  • 1. p16(INK4a) immunostaining as an alternative to histology review for reliable grading of cervical intraepithelial lesions.
    Dijkstra MG; Heideman DA; de Roy SC; Rozendaal L; Berkhof J; van Krimpen K; van Groningen K; Snijders PJ; Meijer CJ; van Kemenade FJ
    J Clin Pathol; 2010 Nov; 63(11):972-7. PubMed ID: 20924035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p16(INK4a) as a complementary marker of high-grade intraepithelial lesions of the uterine cervix. I: Experience with squamous lesions in 189 consecutive cervical biopsies.
    Dray M; Russell P; Dalrymple C; Wallman N; Angus G; Leong A; Carter J; Cheerala B
    Pathology; 2005 Apr; 37(2):112-24. PubMed ID: 16028838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using biomarkers as objective standards in the diagnosis of cervical biopsies.
    Galgano MT; Castle PE; Atkins KA; Brix WK; Nassau SR; Stoler MH
    Am J Surg Pathol; 2010 Aug; 34(8):1077-87. PubMed ID: 20661011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P16INK4a immunohistochemistry improves the reproducibility of the histological diagnosis of cervical intraepithelial neoplasia in cone biopsies.
    Gurrola-Díaz CM; Suárez-Rincón AE; Vázquez-Camacho G; Buonocunto-Vázquez G; Rosales-Quintana S; Wentzensen N; von Knebel Doeberitz M
    Gynecol Oncol; 2008 Oct; 111(1):120-4. PubMed ID: 18692882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-tiered score for Ki-67 and p16
    van Zummeren M; Leeman A; Kremer WW; Bleeker MCG; Jenkins D; van de Sandt M; Heideman DAM; Steenbergen R; Snijders PJF; Quint WGV; Berkhof J; Meijer CJLM
    J Clin Pathol; 2018 Nov; 71(11):981-988. PubMed ID: 30012698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of cervical biopsies of women with HIV and HPV co-infection using p16
    Kremer WW; Vink FJ; van Zummeren M; Dreyer G; Rozendaal L; Doorbar J; Bleeker MCG; Meijer CJLM
    Mod Pathol; 2020 Oct; 33(10):1968-1978. PubMed ID: 32249820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical value of p16
    Song FB; Du H; Xiao AM; Wang C; Huang X; Yan PS; Liu ZH; Qu XF; Belinson JEROMEL; Wu RF
    Zhonghua Fu Chan Ke Za Zhi; 2020 Nov; 55(11):784-790. PubMed ID: 33228350
    [No Abstract]   [Full Text] [Related]  

  • 8. p16INK4a immunohistochemistry in cervical biopsy specimens: A systematic review and meta-analysis of the interobserver agreement.
    Reuschenbach M; Wentzensen N; Dijkstra MG; von Knebel Doeberitz M; Arbyn M
    Am J Clin Pathol; 2014 Dec; 142(6):767-72. PubMed ID: 25389329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjunctive use of p16 immunohistochemistry for optimizing management of CIN lesions in a high-risk human papillomavirus-positive population.
    Ebisch RMF; Rijstenberg LL; Soltani GG; van der Horst J; Vedder JEM; Hermsen M; Bosgraaf RP; Massuger LFAG; Meijer CJLM; Heideman DAM; van Kemenade FJ; Melchers WJG; Bekkers RLM; Siebers AG; Bulten J
    Acta Obstet Gynecol Scand; 2022 Nov; 101(11):1328-1336. PubMed ID: 36177908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conjunctive p16INK4a testing significantly increases accuracy in diagnosing high-grade cervical intraepithelial neoplasia.
    Bergeron C; Ordi J; Schmidt D; Trunk MJ; Keller T; Ridder R;
    Am J Clin Pathol; 2010 Mar; 133(3):395-406. PubMed ID: 20154278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p16INK4A immunohistochemical staining and predictive value for progression of cervical intraepithelial neoplasia grade 1: a prospective study in China.
    Liao GD; Sellors JW; Sun HK; Zhang X; Bao YP; Jeronimo J; Chen W; Zhao FH; Song Y; Cao Z; Zhang SK; Xi MR; Qiao YL
    Int J Cancer; 2014 Apr; 134(7):1715-24. PubMed ID: 24105727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of p16(INK4a) immunohistochemistry staining on interobserver agreement on the diagnosis of cervical intraepithelial neoplasia.
    Pacchiarotti A; Galeotti S; Bellardini P; Chini F; Collina G; Dalla Palma P; Ghiringhello B; Maccallini V; Musolino F; Negri G; Pisa R; Sabatucci I; Giorgi Rossi P
    Am J Clin Pathol; 2014 Mar; 141(3):367-73. PubMed ID: 24515764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p16(INK4a) expression correlates with degree of cervical neoplasia: a comparison with Ki-67 expression and detection of high-risk HPV types.
    Agoff SN; Lin P; Morihara J; Mao C; Kiviat NB; Koutsky LA
    Mod Pathol; 2003 Jul; 16(7):665-73. PubMed ID: 12861062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interlaboratory concordance of p16/Ki-67 dual-staining interpretation in HPV-positive women in a screening population.
    Benevolo M; Mancuso P; Allia E; Gustinucci D; Bulletti S; Cesarini E; Carozzi FM; Confortini M; Bisanzi S; Carlinfante G; Rubino T; Rollo F; Marchi N; Farruggio A; Pusiol T; Venturelli F; Giorgi Rossi P;
    Cancer Cytopathol; 2020 May; 128(5):323-332. PubMed ID: 32168431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic and Treatment Reproducibility of Cervical Intraepithelial Neoplasia / Squamous Intraepithelial Lesion and Factors Affecting the Diagnosis.
    Sağlam A; Usubütün A; Dolgun A; Mutter GL; Salman MC; Kurtulan O; Akyol A; Özkan EA; Baykara S; Bülbül D; Calay Z; Eren F; Gümürdülü D; Haberal N; Ilvan Ş; Karaveli Ş; Koyuncuoğlu M; Müezzinoğlu B; Müftüoğlu KH; Özen Ö; Özdemir N; Peştereli E; Ulukuş Ç; Zekioğlu O
    Turk Patoloji Derg; 2017; 1(1):177-191. PubMed ID: 28832077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunostaining for p16INK4a used as a conjunctive tool improves interobserver agreement of the histologic diagnosis of cervical intraepithelial neoplasia.
    Horn LC; Reichert A; Oster A; Arndal SF; Trunk MJ; Ridder R; Rassmussen OF; Bjelkenkrantz K; Christiansen P; Eck M; Lorey T; Skovlund VR; Ruediger T; Schneider V; Schmidt D
    Am J Surg Pathol; 2008 Apr; 32(4):502-12. PubMed ID: 18223479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigating Diagnostic Problems of CIN1 and CIN2 Associated With High-risk HPV by Combining the Novel Molecular Biomarker PanHPVE4 With P16INK4a.
    van Baars R; Griffin H; Wu Z; Soneji YJ; van de Sandt M; Arora R; van der Marel J; Ter Harmsel B; Jach R; Okon K; Huras H; Jenkins D; Quint W; Doorbar J
    Am J Surg Pathol; 2015 Nov; 39(11):1518-1528. PubMed ID: 26379150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The utility of p16(Ink4a) in discriminating between cervical intraepithelial neoplasia 1 and nonneoplastic equivocal lesions of the cervix.
    Redman R; Rufforny I; Liu C; Wilkinson EJ; Massoll NA
    Arch Pathol Lab Med; 2008 May; 132(5):795-9. PubMed ID: 18466028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p16INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears.
    Murphy N; Ring M; Killalea AG; Uhlmann V; O'Donovan M; Mulcahy F; Turner M; McGuinness E; Griffin M; Martin C; Sheils O; O'Leary JJ
    J Clin Pathol; 2003 Jan; 56(1):56-63. PubMed ID: 12499437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus genotyping and p16INK4a expression in cervical intraepithelial neoplasia of adolescents.
    Hu L; Guo M; He Z; Thornton J; McDaniel LS; Hughson MD
    Mod Pathol; 2005 Feb; 18(2):267-73. PubMed ID: 15492761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.